Status:
COMPLETED
Development and Evaluation of THRIVE
Lead Sponsor:
Children's Hospital of Philadelphia
Conditions:
Oncology
Eligibility:
All Genders
12-25 years
Phase:
NA
Brief Summary
Investigators will test the feasibility and acceptability, as well as efficacy (exploratory aim) of a text messaging intervention for Adolescents and young adults (AYA) transitioning off active treatm...
Detailed Description
Adolescents and young adults (AYA) with cancer are recognized as an understudied and underserved population in oncology. AYA engagement in ongoing disease management is compromised by lack of awarenes...
Eligibility Criteria
Inclusion
- Diagnosed with cancer
- Males or females between the ages of 12 and 25
- In remission (per documentation in chart)
- Within 12 months of completing active treatment for cancer
- Cognitively capable to complete measures (per documentation in chart of impairment or parent or provider report).
- Able to read and speak English.
- Parent available to provide consent for those ages 12 to 17
Exclusion
- 1)Subjects that do not meet inclusion criteria described above will be excluded.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03806140
Start Date
July 1 2014
End Date
January 1 2016
Last Update
January 16 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.